Lataa...
Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas
Resistance to targeted therapies has become increasingly prevalent. We noted that resistance to different targeted therapies occurs by largely common mechanisms. In this study, we used this information for identifying the mechanisms of resistance to enhancer of zeste homolog 2 (EZH2) inhibitors in d...
Tallennettuna:
| Julkaisussa: | Blood |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5946763/ https://ncbi.nlm.nih.gov/pubmed/29572378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-08-804344 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|